v3.25.2
Revenue Recognition and Accounts Receivable - Schedule of Net Sales by Product Category by Reporting Segment (Detail) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Revenue Recognition And Accounts Receivable [Line Items]        
Net sales $ 203,121 $ 198,620 $ 396,767 $ 387,228
Change 2.30%   2.50%  
Bone Growth Therapies [Member]        
Revenue Recognition And Accounts Receivable [Line Items]        
Net sales $ 62,573 59,135 $ 117,623 111,612
Change 5.80%   5.40%  
Spinal Implants, Biologics, and Enabling Technologies [Member]        
Revenue Recognition And Accounts Receivable [Line Items]        
Net sales $ 107,251 108,899 $ 216,037 217,715
Change 1.50%   (0.80%)  
Global Spine [Member]        
Revenue Recognition And Accounts Receivable [Line Items]        
Net sales $ 169,824 168,034 $ 333,660 329,327
Change 1.10%   1.30%  
Global Orthopedics [Member]        
Revenue Recognition And Accounts Receivable [Line Items]        
Net sales $ 33,297 $ 30,586 $ 63,107 $ 57,901
Change 8.90%   9.00%